株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ブラジルの体外診断(IVD)市場の分析

Brazil IVD Market Analysis

発行 Kalorama Information 商品コード 282862
出版日 ページ情報 英文 67 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
ブラジルの体外診断(IVD)市場の分析 Brazil IVD Market Analysis
出版日: 2017年06月16日 ページ情報: 英文 67 Pages
概要

当レポートでは、ブラジルにおける体外診断(IVD)市場を調査し、市場および医療システムの基本構造や、IVDセグメント別の市場動向、競合情勢や主要企業のプロファイルなどを提供しています。

第1章 エグゼクティブサマリー

第2章 ブラジルのIVD概要

  • ブラジルの人口
    • 年央人口:年齢層別
    • 出生率と予測
    • 平均寿命
    • 都市人口
  • 経済 & 医療支出
    • ブラジルのDGPおよび医療支出
    • ブラジルの所得および支出の分布

第3章 ブラジルの医療システム

  • 医療システムの構造
    • 民間・公的医療保険の加入率
    • 民間・公的医療保険の支出額
    • 医療施設
    • 医師・医療従事者
    • 診断施設の環境
    • 医療機器の規制
    • メディカルツーリズム
  • 健康指標
    • 健康状態
    • 疾患概要
    • 外科手術

第4章 ブラジルのIVD市場

  • 市場概要
  • 臨床化学
  • 免疫学的測定法
  • 微生物・分子検査
  • ポイントオブケア
  • 組織学

第5章 競合分析・企業プロファイル

  • 競合情勢
  • ABBOTT LABORATORIES
  • ALERE
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • DANAHER CORPORATION
  • ROCHE
  • SIEMENS HEALTHINEERS
  • SYSMEX CORPORATION

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KLI15386111

The Brazilian in vitro diagnostic (IVD) market is ripe for entry. The country has a growing middle class, stabilizing economy, increasing urban population, and a supportive government. The county is witnessing a major shift toward the private health industry, which supports growth of IVD technologies that are expensive or not typically covered at the public level. An increasing interest in molecular testing technologies, prenatal screening, and point-of-care (POC) glucose testing are driving market growth.

Brazil IVD Market Analysis is designed to provide the reader with an overview of the Brazilian laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:

  • Clinical Chemistry
  • Immunoassays
  • Microbiology and Molecular Testing
  • Point-of-Care Testing

Increasing incidence of non-communicable disease, a steady incidence of infectious diseases, an increasing disease risk with current lifestyle trends (higher obesity rate, lower activity rates), and other factors have contributed to the current and future Brazil IVD market outlook as outlined in the report:

  • Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)
  • Brazil IVD Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)
  • Brazil - Clinical Chemistry Market, 2016-2021
  • Brazil - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
  • Brazil - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • Brazil - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
  • Brazil Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)
  • Brazil POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)
  • Brazil - Histology Market, 2016-2021

Included in Brazil IVD Market Analysis are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

The IVD market is highly competitive worldwide and Latin America is no exception. Brazil's IVD market is dominated by a handful of global competitors, which are profiled in the report:

  • Abbott Laboratories
  • Alere
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Danaher Corporation
  • Roche (F. Hoffman-La Roche, Ltd.)
  • Siemens Healthineers
  • Sysmex Corporation

The information in Brazil IVD Market Analysis was gathered using both primary and secondary research methods including more than 25 interviews completed during the period of April 2017 and June 2017. These interviews were with government officials, medical device regulators, Brazilian-based distributors, health care providers and leading market participants. In some cases, the use of a third-party interpreter service was used to complete the interview. Secondary data included the use of government databases, company literature, medical journals and reports.

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY

  • INDUSTRY OVERVIEW
  • SCOPE AND METHODOLOGY
  • BRAZIL IVD MARKET SUMMARY
    • Figure 1-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other)

CHAPTER 2: BRAZIL OVERVIEW

  • POPULATION
    • Table 2-1: Total Midyear Population by Broad Age Group: Brazil (million persons), 2010-2050 (0-14, 15-64, 65+)
    • Figure 2-1: Total Midyear Population by Broad Age Group: Brazil (million persons), 2010-2050 (0-14, 15-64, 65+)
    • Figure 2-2: Total Number of Births in Brazil by Year, 1970-2010, and Forecast 2020-2050
    • Figure 2-3: Brazil Life Expectancy at Birth in Years, 2010-2050
    • Population Urbanization
  • ECONOMY AND HEALTH SPENDING
    • Figure 2-4: Brazil GDP, GDP (PPP) and Health Spending, 1990-2015
    • Figure 2-5: Brazil Distribution of Income or Consumption by Quintile, 1990-2014

CHAPTER 3: THE HEALTH SYSTEM IN BRAZIL

  • HEALTH INFRASTRUCTURE
    • Figure 3-1: Brazilian Coverage Rate (%) for Private Health Plans and Public Health Plans, 2003-2015 (Private Medical Aid Plan Beneficiaries with or without Dental Care, Public Health Plan Beneficiaries)
    • Figure 3-2: Health Expenditures, Public vs. Private as a % of Total Health Expenditures, 2015 (Private, Public)
    • Medical Facilities
      • Figure 3-3: Distribution of JCI Accredited Facilities by Metropolitan Area (%) (Sao Paulo, Rio de Janeiro, Recife, Brasilia, Porto Alegre, Others)
      • Figure 3-4: Distribution of JCI Accredited Facilities by Type (%) (Hospital Program, Academic Medical Center, Ambulatory Care, Home Care, Medical Transport, Primary Care)
      • Figure 3-5: Hospital Bed Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
    • Physicians and Health Professionals
      • Figure 3-6: Physician Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
      • Figure 3-7: Nurse/Midwife Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
    • The Brazilian Diagnostic Laboratory Environment
      • Figure 3-8: Laboratories and Collection Sites in Brazil by Type (%), 2016 (Collection Sites, all types; Commercial Laboratories; Hospital-based Laboratories)
      • Figure 3-9: Distribution of Volume, Brazil's Leading Clinical Laboratory Service Providers (%), 2016
    • Medical Device Regulation
      • Table 3-1: Market Divers and Inhibitors for Entering Brazil's Medical Device Market
      • Figure 3-10: Market Entry Complexity for Foreign Operators in Brazil
    • Brazil's Growing Medical Tourism Industry
  • HEALTH INDICATORS
    • General Health
    • Disease Profiles in Brazil
      • Table 3-2: Top 5 Cancers Affecting Brazilian Population (ranked by total number of cases), 2010-2016 (Male, Female, Total [both sexes])
      • Figure 3-11: Highly Prevalent Medical Conditions/Diseases in Brazil (Zika virus, Tuberculosis, Malaria, Leprosy, HIV, Diabetes, Dengue, Chagas disease, Cardiovascular diseases, Cancer)
    • Surgical Procedures in Brazil
      • Table 3-3: Surgical Procedures in Brazil as Compared to Rest of Latin America (%) (Cardiovascular procedures, Digestive/Gastrointestinal procedures, Obstetrical/Gynecological procedures, Orthopedic procedures, ENT/Respiratory procedures, Urinary surgical procedures, Cosmetic/Aesthetic procedures, Other procedures, Total)
      • Figure 3-12: Brazil, Mexico and Rest of LATAM Distribution of Population Compared to Surgical Procedures (%)

CHAPTER 4: IVD MARKETS IN BRAZIL

  • BRAZIL IVD MARKET SUMMARY
    • Table 4-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)
    • Figure 4-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other)
    • Figure 4-2: Brazil In Vitro Diagnostic Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)
  • CLINICAL CHEMISTRY
    • Figure 4-3: Brazil - Clinical Chemistry Market, 2016-2021
  • IMMUNOASSAY
    • Table 4-2: Brazil - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
    • Figure 4-4: Brazil - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • MICROBIOLOGY/MOLECULAR
    • Table 4-3: Brazil - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
    • Figure 4-5: Brazil Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • POINT-OF-CARE
    • Table 4-4: Brazil - POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)
    • Figure 4-6: Brazil POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)
  • HISTOLOGY
    • Figure 4-7: Brazil - Histology Market, 2016-2021

CHAPTER 5: COMPETITIVE ANALYSIS AND PROFILES

  • COMPETITIVE SUMMARY
    • Table 5-1: Leading IVD Market Suppliers in Brazil, Market Share Percentage, 2016
    • Figure 5-1: Leading IVD Market Suppliers in Brazil, 2016 (%)
  • ABBOTT LABORATORIES
    • Table 5-2: Abbott Laboratories Company Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • ALERE
    • Table 5-3: Alere Company Summary
    • Company Overview
    • Performance Review
    • Product Summary
  • BECTON, DICKINSON AND COMPANY
    • Table 5-4: Becton, Dickinson and Company Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • BIOMÉRIEUX SA
    • Table 5-5: bioMerieux Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • DANAHER CORPORATION
    • Table 5-6: Danaher Corporation Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • ROCHE (F. HOFFMAN-LA ROCHE, LTD.)
    • Table 5-7: Roche Group Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • SIEMENS HEALTHINEERS
    • Table 5-8: Siemens Healthineers Company Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • SYSMEX CORPORATION
    • Table 5-9: Sysmex Corporation Summary
    • Company Overview
    • Company Performance
    • Product Summary

APPENDIX: SOURCES OF INFORMATION

Back to Top